Search
Search by klickable keywords
acute GVHD
acute kidney injury
acute myeloid leukemia
acute myeloid leukemia (AML)
allogeneic stem cell transplantation
allogeneic stem cell transplantation (SCT)
allogeneic transplantation
antifungal prophylaxis
аnti-thymocyte globulin
apoptosis
auto-HSCT
autologous stem cell transplantation
BCR-ABL
bone formation
bone marrow
bone marrow stem cells
bone marrow transplantation
bone resorption
cancer
carcinogenesis
cardiopulmonary bypass pump
caspofungin
cell culture
cell therapy
chelating therapy
chemotherapy
chronic GVHD
chronic myeloid leukemia
clinical response
clinical trials
c-Met
colony forming unit-fibroblast
colony forming unit-spleen (CFU-S)
colony forming units- fibroblasts (CFU-F)
combined protocol
comparative trials
complications
cord blood
cost of blood transfusion
cost of drugs
co-transplantation
CXCR4
cytogenetic remission
cytogenetics
cytokynesis
differentiation
DKK1
donor registry
early, conventional and salvage transplantation
efficiency
European Leukemia Network
Friedenstein A.J.
G-CSF
gene expression
gene therapy
genotype
Germany
Gorbacheva
graft rejection
graft versus host disease
graft-versus-host disease
graft versus leukemia effect
GVHD
haplotype
harvesting
hematological cancer
hematopoietic ectopic foci
hematopoietic engraftment
hematopoietic stem cells
hematopoietic stem cell transplantation (HSCT)
hematopoietic stem cell transplantation
hepatocyte growth factor
HGF
hierarchy of precursor cells
high-dose chemotherapy
HLA antigens
Hodgkin’s lymphoma
HSCT
human embryonic stem cells
imatinib mesylate
immunomodulation
immunophenotyping
immunotherapy
indication
infectious complications
inflammatory cytokines
inhibitors
invasive mycoses
iron metabolism
iron overload
law
legislation
logistic regression model
long-term bone marrow culture
Maximow A.
mechanism of action
Mesenchymal Stem Cell
mesenchymal stem cells
mesenchymal stem cells (MSC)
mesenchymal stromal cells
mitosis
multiple myeloma
multiple sclerosis
multipotent marrow stromal cells
myeloablative conditioning regimens (MCR)
myeloproliferative disorders
Nanog
Nigeria
Oct-4
oocytes
open heart surgery
OPG
PCR
peripheral blood
phosphatase
phosphorylation
platelet lysate
pluripotency
polymerase chain reaction (PCR)
primary refractory disease
quality of life
quality of life treatment response
RANK
RANKL
reduced toxicity conditioning regimens (RTCR)
regulatory
regulatory framework
regulatory T cell
relapse
retroviral gene transfer
Retrovirus
review
risk factors of invasive mycoses
Russian regions
SSEA
stem cell mobilization
stem cell support
stem cells
steroids
storage
stroma mesenchymal stem cells
symptom treatment response
syngeneic stem cell transplantation
T cell receptor (TCR) gene transfer
therapy
TNF-alpha
transplantation
transplantation outcome
treatment
typing
tyrosine kinase
umbilical cord blood
V617F mutation of JAK2 gene
VSEL
weight coefficient
funded by:
